Intercept Pharmaceuticals Price on August 18, 2022
ICPTDelisted Stock | USD 19.00 0.00 0.00% |
If you're considering investing in Intercept Stock, it is important to understand the factors that can impact its price. As of today, the current price of Intercept Pharmaceuticals stands at 19.00, as last reported on the 24th of April, with the highest price reaching 19.01 and the lowest price hitting 18.98 during the day. We have found twenty-eight technical indicators for Intercept Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please check out Intercept Pharmaceuticals' Risk Adjusted Performance of 0.0867, downside deviation of 2.36, and Market Risk Adjusted Performance of (0.89) to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
Intercept Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Intercept |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
ICPT |
Based on monthly moving average Intercept Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Intercept Pharmaceuticals by adding Intercept Pharmaceuticals to a well-diversified portfolio.
Intercept Pharmaceuticals Valuation on August 18, 2022
It is possible to determine the worth of Intercept Pharmaceuticals on a given historical date. On August 18, 2022 Intercept was worth 18.66 at the beginning of the trading date compared to the closed value of 19.7. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Intercept Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Intercept Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Intercept Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Intercept Pharmaceuticals' related companies.
Open | High | Low | Close | Volume | |
18.00 | 19.27 | 17.74 | 18.73 | 824,000 | |
08/18/2022 | 18.66 | 19.70 | 18.02 | 19.70 | 1,746,400 |
19.03 | 21.25 | 17.58 | 17.74 | 4,272,500 |
Backtest Intercept Pharmaceuticals | | | Intercept Pharmaceuticals History | | | Intercept Pharmaceuticals Valuation | Previous | Next |
Intercept Pharmaceuticals Trading Date Momentum on August 18, 2022
On August 19 2022 Intercept Pharmaceuticals was traded for 17.74 at the closing time. The top price for the day was 21.25 and the lowest listed price was 17.58 . The trading volume for the day was 4.3 M. The trading history from August 19, 2022 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 9.95% . The trading delta at closing time against the current closing price is 8.53% . |
Intercept Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Intercept Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Intercept Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Intercept financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Intercept Pharmaceuticals Stock history
Intercept Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Intercept is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Intercept Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Intercept Pharmaceuticals stock prices may prove useful in developing a viable investing in Intercept Pharmaceuticals
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company was incorporated in 2002 and is headquartered in New York, New York. Intercept Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 437 people.
Intercept Pharmaceuticals Stock Technical Analysis
Intercept Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Intercept Pharmaceuticals Period Price Range
Low | August 18, 2022
| High |
18.66 | 19.70 |
Intercept Pharmaceuticals April 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Intercept Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Intercept Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Intercept Pharmaceuticals stock market strength indicators, traders can identify Intercept Pharmaceuticals entry and exit signals to maximize returns
Intercept Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Intercept Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Intercept Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Intercept to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0867 | |||
Jensen Alpha | 1.35 | |||
Total Risk Alpha | (0.04) | |||
Sortino Ratio | 0.4932 | |||
Treynor Ratio | (0.90) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Intercept Stock
If you are still planning to invest in Intercept Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intercept Pharmaceuticals' history and understand the potential risks before investing.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Stocks Directory Find actively traded stocks across global markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |